Factors associated with early hormonal therapy for prostate cancer.

被引：0
|
作者：
Kucera, G [1 ]
Yood, MU [1 ]
Demers, R [1 ]
Divine, G [1 ]
Wells, K [1 ]
Tiwari, A [1 ]
机构：
[1] Henry Ford Hlth Syst, Detroit, MI 48202 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2003年 / 157卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
42
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [41] Endocrine therapy metastatic prostate cancer.
    Ruffion, A
    Fontaine, E
    Staerman, F
    PROGRES EN UROLOGIE, 2003, 13 (02): : 334 - 341
  • [42] Gene therapy vectors prostate cancer.
    Zhang, JF
    Kasper, S
    Koch, MO
    Smith, JA
    Matusik, RJ
    JOURNAL OF UROLOGY, 1998, 159 (05): : 10 - 10
  • [43] Examining factors associated with adherence to hormonal therapy in breast cancer patients
    Shah, Chintal H.
    Balkrishnan, Rajesh
    Diaby, Vakaramoko
    Xiao, Hong
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2020, 16 (04): : 574 - 582
  • [44] Early biochemical failure after radical prostatectomy for prostate cancer. Impact factors?
    Blanco Diez, A.
    Armas Molina, J.
    Liminana Canal, J. M.
    Jimenez Garcia, C.
    Artiles Hernndez, J. L.
    Chesa Ponce, N.
    ACTAS UROLOGICAS ESPANOLAS, 2008, 32 (04): : 406 - 410
  • [45] Hormonal and reproductive risk factors for fatal breast cancer.
    Poole, Elizabeth M.
    Eliassen, A. Heather
    Hankinson, Susan E.
    Rosner, Bernard A.
    Willett, Walter C.
    Tamimi, Rulla M.
    Tworoger, Shelley S.
    CANCER RESEARCH, 2013, 73 (08)
  • [46] Prognostic factors in radiotherapy of prostate cancer. Importance of dose and induction hormone therapy
    Leborgne, Felix
    Leborgne, Jose H.
    Ortega, Bettys
    Curochquin, Rene
    Julieta Mezzera, Bioestadistica
    Mullin, Mercedes
    REVISTA MEDICA DEL URUGUAY, 2008, 24 (01): : 5 - 14
  • [47] Hormonal Therapy Compliance and Mortality in Metastatic Breast Cancer.
    Barron, T. I.
    Kennedy, M. J.
    Sharp, L.
    Bennett, K.
    CANCER RESEARCH, 2011, 71
  • [48] The changing face of hormonal therapy for prostate cancer
    Seruga, B.
    Tannock, I. F.
    ANNALS OF ONCOLOGY, 2008, 19 : 79 - 85
  • [49] Reasons for changing hormonal therapy of advanced breast cancer.
    Petrakova, Katarina
    Petruzelka, Lubos B.
    Kandrnal, Vit
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Treatment of prostate cancer with hormonal therapy in Europe
    Miller, Kurt
    Anderson, John
    Abrahamsson, Per-Anders
    BJU INTERNATIONAL, 2009, 103 : 2 - 6
12345